RESMED INC Quarterly Goodwill in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Resmed Inc quarterly Goodwill history and growth rate from Q2 2010 to Q2 2024.
  • Resmed Inc Goodwill for the quarter ending June 30, 2024 was $2.84B, a 2.59% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.84B +$71.8M +2.59% Jun 30, 2024 10-K 2024-08-09
Q1 2024 $2.84B +$52.4M +1.88% Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $2.86B +$94.7M +3.42% Dec 31, 2023 10-Q 2024-01-25
Q3 2023 $2.81B +$873M +45% Sep 30, 2023 10-Q 2023-10-27
Q2 2023 $2.77B +$834M +43.1% Jun 30, 2023 10-K 2024-08-09
Q1 2023 $2.78B +$837M +43% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 $2.77B +$816M +41.8% Dec 31, 2022 10-Q 2023-01-27
Q3 2022 $1.94B +$16.8M +0.87% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $1.94B +$8.54M +0.44% Jun 30, 2022 10-K 2023-08-11
Q1 2022 $1.95B +$20.3M +1.06% Mar 31, 2022 10-Q 2022-04-29
Q4 2021 $1.95B +$41M +2.14% Dec 31, 2021 10-Q 2022-01-28
Q3 2021 $1.92B +$22.3M +1.17% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $1.93B +$37.6M +1.99% Jun 30, 2021 10-K 2022-08-12
Q1 2021 $1.93B +$41.5M +2.2% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $1.91B +$39.8M +2.13% Dec 31, 2020 10-Q 2021-01-29
Q3 2020 $1.9B +$43.3M +2.33% Sep 30, 2020 10-Q 2020-10-30
Q2 2020 $1.89B +$33.9M +1.83% Jun 30, 2020 10-K 2021-08-17
Q1 2020 $1.88B -$54.7M -2.82% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $1.87B +$112M +6.34% Dec 31, 2019 10-Q 2020-01-31
Q3 2019 $1.86B +$664M +55.7% Sep 30, 2019 10-Q 2019-10-25
Q2 2019 $1.86B +$788M +73.7% Jun 30, 2019 10-K 2020-08-13
Q1 2019 $1.94B +$858M +79.4% Mar 31, 2019 10-Q 2019-05-03
Q4 2018 $1.76B +$684M +63.6% Dec 31, 2018 10-Q 2019-02-01
Q3 2018 $1.19B +$120M +11.2% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 $1.07B +$4.07M +0.38% Jun 30, 2018 10-K 2019-08-08
Q1 2018 $1.08B +$30.9M +2.94% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $1.08B +$29M +2.77% Dec 31, 2017 10-Q 2018-01-24
Q3 2017 $1.07B +$9.54M +0.9% Sep 30, 2017 10-Q 2018-10-26
Q2 2017 $1.06B +$5.63M +0.53% Jun 30, 2017 10-Q 2018-10-26
Q1 2017 $1.05B +$592M +129% Mar 31, 2017 10-Q 2018-04-27
Q4 2016 $1.05B +$673M +180% Dec 31, 2016 10-Q 2018-01-24
Q3 2016 $1.06B +$800M +304% Sep 30, 2016 10-Q 2017-10-27
Q2 2016 $1.06B +$795M +301% Jun 30, 2016 10-K 2018-08-17
Q1 2016 $458M +$203M +79.3% Mar 31, 2016 10-Q 2017-04-28
Q4 2015 $373M +$100M +36.9% Dec 31, 2015 10-Q 2017-01-25
Q3 2015 $263M -$14.4M -5.21% Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $264M -$25.1M -8.66% Jun 30, 2015 10-K 2017-08-04
Q1 2015 $256M -$35.2M -12.1% Mar 31, 2015 10-Q 2016-04-29
Q4 2014 $273M -$17.4M -6.01% Dec 31, 2014 10-Q 2016-01-28
Q3 2014 $277M -$6.18M -2.18% Sep 30, 2014 10-Q 2015-10-27
Q2 2014 $289M +$14.5M +5.27% Jun 30, 2014 10-K 2016-08-05
Q1 2014 $291M +$18M +6.59% Mar 31, 2014 10-Q 2015-04-29
Q4 2013 $290M +$10.7M +3.82% Dec 31, 2013 10-Q 2015-01-30
Q3 2013 $283M +$10.2M +3.72% Sep 30, 2013 10-Q 2014-10-31
Q2 2013 $275M +$18.6M +7.27% Jun 30, 2013 10-K 2015-08-07
Q1 2013 $273M +$4.97M +1.86% Mar 31, 2013 10-Q 2014-05-01
Q4 2012 $279M +$18.3M +7% Dec 31, 2012 10-Q 2014-01-29
Q3 2012 $273M +$5.59M +2.09% Sep 30, 2012 10-Q 2013-10-30
Q2 2012 $256M +$20.7M +8.8% Jun 30, 2012 10-K 2014-08-08
Q1 2012 $268M +$37M +16% Mar 31, 2012 10-Q 2013-05-01
Q4 2011 $261M +$41.9M +19.1% Dec 31, 2011 10-Q 2013-01-31
Q3 2011 $268M +$45.4M +20.4% Sep 30, 2011 10-Q 2012-10-31
Q2 2011 $235M +$36.9M +18.6% Jun 30, 2011 10-K 2013-08-13
Q1 2011 $231M Mar 31, 2011 10-Q 2011-05-03
Q4 2010 $219M Dec 31, 2010 10-Q 2011-02-03
Q3 2010 $222M Sep 30, 2010 10-Q 2010-11-03
Q2 2010 $199M Jun 30, 2010 10-K 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.